Hantavirus vaccine trial for cruise workers by 2028

A pharmaceutical company will announce the first successful human trials of a hantavirus vaccine specifically targeting cruise ship workers by Q2 2028. This will be driven by heightened demand for occupational safety measures.

Implied probability (Yes)

60%